The accuracy of a blood test depends entirely on what you’re trying to measure and whether the right test is being used. Some blood tests are remarkably precise, with accuracy rates above 99%, while others are frequently misinterpreted or poorly suited to the question being asked. Here’s a breakdown of the most reliable blood tests available for common health concerns, what makes them accurate, and where the pitfalls are.
Blood Sugar and Diabetes Screening
The HbA1c test (sometimes called A1c) is the standard blood test for diagnosing and monitoring diabetes. It measures your average blood sugar over the previous two to three months by looking at how much sugar has attached to your red blood cells. For most people, it gives a reliable picture of blood sugar control and doesn’t require fasting.
However, A1c has a significant blind spot. Any condition that changes how long your red blood cells survive will throw off the result. If your red blood cells are being destroyed faster than normal, as happens with hemolytic anemia, your A1c will read falsely low, potentially masking diabetes. Iron deficiency anemia pushes the number in the other direction, making blood sugar look worse than it actually is. People with sickle cell trait, sickle cell disease, or other hemoglobin variants also get unreliable A1c readings. For patients on dialysis, A1c tends to underestimate blood sugar levels, and a different test measuring sugar attached to a blood protein called albumin gives a more reliable picture.
If you have any of these conditions, direct glucose monitoring (finger sticks or a continuous glucose monitor) is more trustworthy than A1c alone.
Prenatal Screening for Chromosomal Conditions
Non-invasive prenatal testing, known as NIPT, analyzes fragments of fetal DNA circulating in a pregnant person’s blood. For detecting Down syndrome, a large meta-analysis published in BMJ Open found NIPT catches 99.3% of cases, with a specificity of 99.9%. Detection rates for Edwards syndrome and Patau syndrome are similarly high, around 97.4%.
The catch is that a positive result doesn’t guarantee the condition is present. In the general population, where these conditions are relatively rare, a positive NIPT result for Down syndrome would still be wrong roughly one time out of every five. In higher-risk populations (older maternal age, abnormal ultrasound findings), the test’s positive results are far more reliable. This is why a positive NIPT always needs confirmation through amniocentesis or chorionic villus sampling before any decisions are made. NIPT is an outstanding screening tool, not a diagnostic one.
Alzheimer’s Disease
The FDA cleared the first blood test for diagnosing Alzheimer’s disease in 2025. It measures the ratio of two proteins in the blood: a form of tau protein and a fragment of amyloid. In a clinical study of 499 cognitively impaired adults, 91.7% of people who tested positive actually had amyloid plaques confirmed by brain scans or spinal fluid testing. Among those who tested negative, 97.3% truly had no amyloid buildup.
This is a major shift. Previously, confirming Alzheimer’s required either a PET scan costing thousands of dollars or an invasive spinal tap. A blood draw that performs this well makes early, accurate diagnosis far more accessible, particularly for people in the early stages of memory problems who need to know whether Alzheimer’s pathology is the cause.
Heart Disease Risk: Beyond Cholesterol
Standard cholesterol panels are well established, but one blood test that’s gaining recognition is for lipoprotein(a), often written as Lp(a). This is a genetically determined particle that raises your risk of heart attack and stroke independently of regular LDL cholesterol. Unlike LDL, Lp(a) levels are mostly set by your genes and don’t change much with diet or exercise.
Major cardiology organizations, including the American College of Cardiology, the European Atherosclerotic Society, and the National Lipid Association, flag levels above 50 mg/dL (or 100 to 125 nmol/L depending on the guideline) as a meaningful risk factor. Because your Lp(a) level is genetically stable, you only need to test it once in your lifetime. If it’s elevated, your doctor may recommend more aggressive management of the risk factors you can control, like LDL cholesterol or blood pressure. The test itself is straightforward and accurate. The problem is that many people have never had it ordered.
Liver Fibrosis Without a Biopsy
Liver biopsy used to be the only way to determine how much scarring (fibrosis) your liver had developed. Now, several blood-based scoring systems can provide a reliable estimate without a needle in your liver.
FibroSure (also called FibroTest) combines several blood markers into a single score. When it was developed for hepatitis C patients, it showed a positive predictive value above 90% for significant fibrosis and a negative predictive value of 100%, meaning it was extremely good at ruling fibrosis out when the score was low. Other scoring systems use simpler calculations from routine blood work. The FIB-4 index, for example, uses your age, liver enzyme levels, and platelet count. A low FIB-4 score (below 1.45) rules out advanced fibrosis with about 90% confidence. A high score (above 3.25) correctly identifies advanced fibrosis about 65% of the time.
These tests work best at the extremes. If your score is clearly low or clearly high, you can trust the result. Scores that fall in the middle range often still require imaging or biopsy to get a definitive answer.
Multi-Cancer Early Detection
Blood tests that screen for dozens of cancer types at once are now commercially available. These tests look for fragments of DNA shed by tumors into the bloodstream. The appeal is obvious: a single blood draw that could catch cancers that have no routine screening, like pancreatic, ovarian, or liver cancer.
The accuracy picture is more complicated than the marketing suggests. According to the American Cancer Society, over half of people who get a positive result on current multi-cancer detection tests turn out not to have cancer after follow-up testing. That’s a false positive rate that creates significant anxiety and leads to additional imaging, biopsies, and medical costs for people who are ultimately fine. These tests also miss many early-stage cancers entirely. They’re most sensitive for advanced cancers, which somewhat undermines the goal of early detection. This technology is evolving rapidly, but for now, a positive result is far from a definitive cancer diagnosis, and a negative result doesn’t mean you’re cancer-free.
Food Allergies vs. Food Sensitivities
If you’re looking for an accurate blood test for food reactions, the distinction between allergy and sensitivity matters enormously. IgE blood tests measure antibodies your immune system produces during a true allergic reaction. These are medically validated and, when combined with your symptoms and history, help diagnose genuine food allergies to things like peanuts, shellfish, or eggs.
IgG food sensitivity panels are a different story entirely. These tests, widely marketed by direct-to-consumer companies, measure IgG antibodies to 90 or more foods and claim to identify foods causing symptoms like bloating, fatigue, or headaches. The American Academy of Allergy, Asthma & Immunology has recommended against using IgG testing for this purpose. The presence of IgG antibodies to a food is a normal immune response to eating that food. Higher levels of IgG4 to a food may actually indicate tolerance, not sensitivity. Eliminating foods based on IgG results can lead to unnecessarily restrictive diets with no symptom improvement. If you suspect food sensitivities, a structured elimination diet guided by a healthcare provider is more reliable than any panel test currently on the market.
How Fasting Affects Accuracy
Some of the most common blood tests require you to skip food for 8 to 12 hours beforehand to get accurate results. Blood glucose tests and lipid panels (cholesterol and triglycerides) are the most frequent examples. A basic metabolic panel, which checks electrolytes, kidney function, and blood sugar, typically requires fasting as well. Liver function tests and kidney panels may or may not require fasting depending on whether they’re ordered as part of a broader panel.
Eating before a fasting test doesn’t just slightly skew the numbers. Triglycerides, for instance, can spike dramatically after a meal, making your results look abnormally high when your actual baseline is perfectly normal. If you accidentally eat before a fasting blood draw, mention it to the person drawing your blood rather than hoping it won’t matter. Repeating the test is better than making treatment decisions based on inaccurate numbers.
Biological Age Testing
Epigenetic clocks are blood tests that estimate your biological age by measuring chemical modifications on your DNA. These modifications change predictably as you age, and the best current algorithms correlate with chronological age at 0.96 or higher on a scale where 1.0 would be a perfect match. That’s impressively precise for research purposes.
In practice, though, the results vary depending on which algorithm is used. Different epigenetic clocks, developed by different research groups, produce correlation values ranging from about 0.78 to 0.89 in validation studies. What this means for an individual is that your “biological age” result could differ by several years depending on which company or test you use. These tests are useful for tracking trends over time, especially in longevity research, but a single result shouldn’t be taken as a precise medical measurement.